Review: HIV infection and tropical parasitic diseases - deleterious interactions in both directions?

被引:70
作者
Harms, G
Feldmeier, H
机构
[1] Inst Trop Med Berlin, D-14050 Berlin, Germany
[2] Humboldt Univ, Fac Med Charite, Berlin, Germany
[3] Free Univ Berlin, Ctr Hlth Sci & Humanities, Inst Social Med, Fac Med, D-1000 Berlin, Germany
关键词
HIV; interaction; tropical parasitic diseases;
D O I
10.1046/j.1365-3156.2002.00893.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
HIV and parasitic infections interact and affect each other mutually. Whereas HIV infection may alter the natural history of parasitic diseases, impede rapid diagnosis or reduce the efficacy of antiparasitic treatment, parasitoses may facilitate the infection with HIV as well as the progression from asymptomatic infection to AIDS. We review data on known interactions for malaria, leishmaniasis, Human African Trypanosomiasis, Chagas' disease, onchocerciasis, lymphatic filariasis, schistosomiasis and intestinal helminthiases. The common immunopathogenetic basis for the deleterious effects parasitic diseases may have on the natural history of HIV infection seems to be a particular type of chronic immune activation and a preferential activation of the T helper (Th)2 type of help. Control of parasitic diseases should complement the tools currently used in combating the HIV pandemic.
引用
收藏
页码:479 / 488
页数:10
相关论文
共 116 条
[1]   HELMINTH INFECTION RESULTS IN DECREASED VIRUS-SPECIFIC CD8+ CYTOTOXIC T-CELL AND TH1-CYTOKINE RESPONSES AS WELL AS DELAYED VIRUS CLEARANCE [J].
ACTOR, JK ;
SHIRAI, M ;
KULLBERG, MC ;
BULLER, RML ;
SHER, A ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :948-952
[2]   Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases [J].
Agostoni, C ;
Dorigoni, N ;
Malfitano, A ;
Caggese, L ;
Marchetti, G ;
Corona, S ;
Gatti, S ;
Scaglia, M .
INFECTION, 1998, 26 (02) :93-99
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS AND MALARIA IN A REPRESENTATIVE SAMPLE OF CHILDBEARING WOMEN IN KIGALI, RWANDA [J].
ALLEN, S ;
VANDEPERRE, P ;
SERUFILIRA, A ;
LEPAGE, P ;
CARAEL, M ;
DECLERCQ, A ;
TICE, J ;
BLACK, D ;
NSENGUMUREMYI, F ;
ZIEGLER, J ;
LEVY, J ;
HULLEY, S .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) :67-71
[4]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[5]  
ATTILI VR, 1983, BRIT J VENER DIS, V59, P269
[6]   LEISHMANIASIS OF THE TONGUE TREATED WITH LIPOSOMAL AMPHOTERICIN-B [J].
BAILY, GG ;
PITT, MA ;
CURRY, A ;
HABOUBI, NY ;
TUFFIN, JR ;
MANDAL, BK .
JOURNAL OF INFECTION, 1994, 28 (03) :327-331
[7]   Concurrent infections and HIV pathogenesis [J].
Bentwich, Z ;
Maartens, G ;
Torten, D ;
Lal, AA ;
Lal, RB .
AIDS, 2000, 14 (14) :2071-2081
[8]  
Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1
[9]   IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS [J].
BENTWICH, Z ;
KALINKOVICH, A ;
WEISMAN, Z .
IMMUNOLOGY TODAY, 1995, 16 (04) :187-191
[10]   HIV viral load and response to antileishmanial chemotherapy in co-infected patients [J].
Berhe, N ;
Wolday, D ;
Hailu, A ;
Abraham, Y ;
Ali, A ;
Gebre-Michael, T ;
Desjeux, P ;
Sönnerborg, A ;
Akuffo, H ;
Britton, S .
AIDS, 1999, 13 (14) :1921-1925